Clinical Trial Update: Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacokinetics and pharmacodynamics of different AZD3199 dry powder inhalation formulations in asthma patients; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD3199

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-03-05